Nardi, Valentina <br/><br/>
ICSBP-mediated immune protection against BCR-ABL-induced leukemia requires the CCL6 and CCL9 chemokines.  [electronic resource] 

 -  Blood  Apr 2009 
 - 3813-20 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood-2008-07-167189  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Chemokines, CC--biosynthesis<br/>Disease Models, Animal<br/>Female<br/>Gene Expression Regulation, Leukemic--drug effects<br/>Genes, abl--immunology<br/>Humans<br/>Interferon Regulatory Factors--biosynthesis<br/>Interferon Type I--immunology<br/>K562 Cells<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Macrophage Inflammatory Proteins--biosynthesis<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Knockout